Crinetics Pharmaceuticals (NASDAQ:CRNX) PT Raised to $69.00 at HC Wainwright
Crinetics Pharmaceuticals (NASDAQ:CRNX – Get Free Report) had its price objective increased by equities research analysts at HC Wainwright from $60.00 to $69.00 in a research note issued on Friday, Benzinga reports. The firm presently has a “buy” rating on the stock. HC Wainwright’s target price would suggest a potential upside of 44.84% from the […]
More Stories
QUINT Self Reported Market Capitalization Achieves $1.17 Million (QUINT)
QUINT (QUINT) traded up 1% against the U.S. dollar during the 1-day period ending at 10:00 AM E.T. on December...
Terra Price Reaches $0.44 on Top Exchanges (LUNA)
Terra (LUNA) traded down 0.4% against the dollar during the 1 day period ending at 10:00 AM E.T. on December...
Axie Infinity (AXS) Reaches Self Reported Market Cap of $1.02 Billion
Axie Infinity (AXS) traded 1.7% higher against the US dollar during the one day period ending at 10:00 AM ET...
TerraClassicUSD (USTC) Price Hits $0.0204
TerraClassicUSD (USTC) traded down 0.8% against the US dollar during the 24 hour period ending at 10:00 AM Eastern on...
GENinCode (LON:GENI) Trading Up 2.9% – Should You Buy?
GENinCode Plc (LON:GENI – Get Free Report)’s stock price traded up 2.9% during trading on Thursday . The company traded...
Toray Industries, Inc. (OTCMKTS:TRYIY) Short Interest Update
Toray Industries, Inc. (OTCMKTS:TRYIY – Get Free Report) was the target of a large decline in short interest in the...